RxDoctor Payments Data

Samantha Lambert

Adult Health · Upper Sandusky, OHNPI 1174299002

Payments from drug & device makers

$735in general payments, 2019–2025

Across 33 payments — averaging $22.27 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Novartis$223
  • Shockwave Medical, Inc$179
  • Johnson & Johnson$98
  • Pfizer$71
  • ZOLL Services LLC (a/k/a ZOLL Lifecor Corp)$43
  • E.r. Squibb & Sons, L.L.C.$32
  • plus $91 from 4 others

What the payments were for

  • Food & beverage$72198%
  • Education$142%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$735 in reported general payments places this provider in the 65th percentile of 1,184 adult health providers in Ohio.

See all adult health providers in Ohio

Medicare billing

Part B allowed, 2024
$18,259
Medicare patients
153
Services billed
252

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
EliquisApixaban59$34,741
XareltoRivaroxaban16$13,564
ClopidogrelClopidogrel Bisulfate106$801
Nitroglycerin35$801
Metoprolol Succinate75$575
Atorvastatin Calcium76$567
Amiodarone Hcl33$325
Diltiazem 24hr Er (Cd)Diltiazem Hcl17$290
Losartan Potassium51$267
Isosorbide Mononitrate ErIsosorbide Mononitrate42$233
Lisinopril31$232
Flecainide Acetate14$215
Spironolactone58$188
Metoprolol Tartrate55$123
Amlodipine Besylate14$123

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
PfizerEliquis$71$34,74159 claims
Johnson & JohnsonXarelto$98$13,56416 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 65th percentile of 1,184 adult health providers in Ohio.

Other adult health in Upper Sandusky

See the full list for Ohio

Where these figures come from

Is this you, or does something look wrong? →